modified T-cells
T-cell receptors
cellular therapy
CAR therapy
cellular cancer therapy
simplified CAR T-cell technologies
cancer cells
commercialisation of CAR T-cell tools
modified cellular products
cost-efficient manufacture of CAR
translation of cellular therapies
somatic cells
safer cellular products
modified ATMP
Advanced Therapies Chimeric antigen receptors
advanced enabling technologies
generation cell processing tools
automated GMP-compliant manufacture of gene
innovative CARs design
Recent success stories of cancer therapy
artificial surface receptors
respect
improved gene delivery
ill patients
integrated CARAT process
comprehensive CARAT platform
particular technological breakthrough
overall aiming
recognition molecules
antibodies
public expectations
genetic engineering
incurable solid tumours
current hurdles
development
technology
handle
CliniMACS Prodigy
hematologic malignancies
global leader
target activity
clinics
envisaged project
proof
concept
safety
potency
vision
care
regulatory compliance
level of standard
Europe
obstacles
summary